Blackstone Raises $6.3B Life Sciences Fund Record
NEW YORK & CAMBRIDGE, Mass., USA, March 30, 2026 Blackstone has announced the final close of Blackstone Life Sciences...
Biotech Investment
Advertisement
CNS Pharmaceuticals Launches Strategy to Build Neurology and Oncology Drug Pipeline
Houston, Texas, United States — March 11, 2026 Biotechnology company CNS Pharmaceuticals has announced the launch of a new...
Dianthus Therapeutics Prices $250M Public Offering
New York, United States — March 10, 2026 Biotechnology company Dianthus Therapeutics has announced the pricing of an upsized...
BioXcel Therapeutics Secures $8M Registered Direct Offering
NEW HAVEN, Connecticut — March 10, 2026 Biotechnology company BioXcel Therapeutics Inc. has announced a registered direct offering expected...
Dianthus Therapeutics Launches $400M Public Offering Plan
New York, United States & Waltham, Massachusetts – March 9, 2026 Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused...
Advertisements
Trimmune JV Financing Fuels Next-Gen Immunotherapy Development
MIRAMAR, Fla., Feb. 16, 2026 — Clinical-stage immunotherapy innovator HCW Biologics and recombinant biologics developer WY Biotech have closed...
Portal Innovations Expands Life Sciences Incubator Network
PROVIDENCE, R.I., Feb. 11, 2026 — Portal Innovations announced the expansion of its Powered by Portal venture development platform...
4Moving Biotech Raises €12M for OA Drug Development
Lille & Paris, France — February 10, 2026: 4Moving Biotech (4MB), a clinical-stage biotechnology company and spin-off of 4P-Pharma,...
LifeArc Ventures Scales Global VC Portfolio in Life Sciences
London, United Kingdom | January 29, 2026 — LifeArc Ventures, the venture capital arm of medical research organization LifeArc,...
Restart Life Secures Oversubscribed Financing to Advance Growth
Vancouver, British Columbia, December 18, 2025 — Restart Life Sciences Corp., a Canadian-based life sciences company, has successfully closed...
Advertisement
